Position in INVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,062,828
+$26,887 QoQ
Shares Held
46,800
+5.3% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#105
of 306 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Horizon Investments, LLC holds $37,596,715 across 22 Biotechnology names. INVA ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,215 | $11,034,856 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,799 | $6,733,608 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
18,295 | $4,408,546 | |
| 4 | EXEL |
Exelixis, Inc.
|
60,084 | $3,269,170 | |
| 5 | INCY |
Incyte Corp
|
22,774 | $2,581,660 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
40,323 | $2,307,282 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
46,510 | $1,645,988 | |
| 8 | INVA |
Innoviva, Inc.
This page
|
46,800 | $1,062,828 |
All Filings in INVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,062,828 | 46,800 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,035,941 | 44,461 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $831,643 | 41,603 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $498,882 | 27,336 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $491,100 | 24,445 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||